Cruiser Capital Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Cruiser Capital Advisors’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-92,400	Closed	-$930K	–	84
2022 Q4	$930K	Hold	92,400	–	–	0.65%	19
2022 Q3	$915K	Hold	92,400	–	–	0.79%	19
2022 Q2	$904K	Hold	92,400	–	–	0.73%	18
2022 Q1	$904K	Hold	92,400	–	–	0.77%	19
2021 Q4	$898K	Hold	92,400	–	–	0.63%	22
2021 Q3	$901K	Hold	92,400	–	–	0.74%	25
2021 Q2	$892K	Buy	+92,400	New	+$903K	0.75%	20

Cruiser Capital Advisors's MSAC Position: Q1 2023 in Review

Cruiser Capital Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 92,400 shares — an estimated $930K sold.

Cruiser Capital Advisors first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $930K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Cruiser Capital Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Cruiser Capital Advisors sold 92,400 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $930K.
Cruiser Capital Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Cruiser Capital Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $930K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Cruiser Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.